The West Virginia Supreme Court of Appeals on Wednesday will become the latest top state court to weigh whether consumers can sue the makers of brand-name pharmaceutical products over injuries allegedly caused by generic versions of the drugs.
The arguments come in a lawsuit against Johnson & Johnson by a West Virginia woman who said that she developed acute respiratory distress syndrome after taking a generic version of the companyâ€™s antibiotic Levaquin made by another company.
To read the full story on WestlawNext Practitioner Insights, click here: bit.ly/2EOojtJ
 